Drug: Vemlidy (tenofovir alafenamide)

Manufacturer: Gilead

Route of Administration: Oral

Site of Care: Outpatient

Approved Indication: treatment of chronic hepatitis B virus infection in adults and pediatric patients 6 years of age and older and weighing at least 25 kg with compensated liver disease

Disease: chronic viral hepatitis B

Therapeutic Area: Infectious disease, Gastroenterology, Hepatology

Enrollment Form Link: My Support Path

Phone Number: 1-855-769-7284

Fax Number: N/A

Product Website: vemlidy.com